维普中文期刊产品整合服务
6篇 您的检索式:作者名="Massimo Giuseppe Colombo"
    题名 作者 年代 出处 被引量
1Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy显示文摘Massimo Iavarone Giuseppe Cabibbo Fabio Piscaglia Claudio Zavaglia Antonio Grieco Erica Villa Calogero Cammà Massimo Colombo 2011Hepatology2011,,6:2
2Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment显示文摘Flavio Airoldi Antonio Colombo Nuccia Morici Azeem Latib John Cosgrave Lutz Buellesfeld Erminio Bonizzoni Mauro Carlino Ulrich Gerckens Cosmo Godino Gloria Melzi Iassen Michev Matteo Montorfano Giuseppe Massimo Sangiorgi Asif Qasim Alaide Chieffo Carlo Br 2007Circulation2007,,7:1
3Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment显示文摘Flavio Airoldi Antonio Colombo Nuccia Morici Azeem Latib John Cosgrave Lutz Buellesfeld Erminio Bonizzoni Mauro Carlino Ulrich Gerckens Cosmo Godino Gloria Melzi Iassen Michev Matteo Montorfano Giuseppe Massimo Sangiorgi Asif Qasim Alaide Chieffo Carlo Br 2007Circulation2007,,:1
4Refining sorafenib therapy: lessons from clinical practice显示文摘Luigi Bolondi Antonio Craxi Franco Trevisani Bruno Daniele Giovan Giuseppe Di Costanzo Stefano Fagiuoli Calogero Cammà Paolo Bruzzi Romano Danesi Federico Spandonaro Corrado Boni Armando Santoro Massimo Colombo 2015Future Oncol2015,,3:1
5Metabolic syndrome after liver transplantation: Short-term prevalence and pre- and post-operative risk factors显示文摘Maria Elena Lunati Valeria Grancini Francesca Agnelli Stefano Gatti Benedetta Masserini Dario Zimbalatti Giuseppe Pugliese Giorgio Rossi Maria Francesca Donato Massimo Colombo Paolo Beck-Peccoz Emanuela Orsi 2013Digestive and Liver Disease2013,,10:1
6Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions显示文摘Globally, 69.6 million individuals were infected with hepatitis C virus (HCV) infection in 2016. Of the six major HCV genotypes (GT), the most predominant one is GT1, worldwide. The prevalence of HCV in Central Asia, which includes most of the Commonwealth of Independent States (CIS), has been estimated to be 5.8% of the total global burden. The predominant genotype in the CIS and Ukraine regions has been reported to be GT1, followed by GT3. Inadequate HCV epidemiological data, multiple socio-economic barriers, and the lack of regionspecific guidelines have impeded the optimal management of HCV infection in this region. In this regard, a panel of regional experts in the field of hepatology convened to discuss and provide recommendations on the diagnosis, treatment, and pre-, on-, and posttreatment assessment of chronic HCV infection and to ensure the optimal use of cost-effective antiviral regimens in the region. A comprehensive evaluation of the literature along with expert recommendations for the management of GT1-GT6 HCV infection with the antiviral agents available in the region has been provided in this review. This consensus document will help guide clinical decision-making during the management of HCV infection, further optimizing treatment outcomes in these regions.Massimo Giuseppe Colombo Erkin Isakovich Musabaev Umed Yusupovich Ismailov Igor A Zaytsev Alexander V Nersesov Igor Anatoliyevich Anastasiy Igor Alexandrovich Karpov Olga A Golubovska Kulpash S Kaliaskarova Ravishankar AC Sanjay Hadigal 2019World Journal of Gastroenterology2019,25,29:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费